Spots Global Cancer Trial Database for Chlorhydrate of Ropivacaine and Breast Cancer Surgery

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Chlorhydrate of Ropivacaine and Breast Cancer Surgery

Official Title: Efficacy of Infiltration of Chlorhydrate of Ropivacaine in the Prevention of Chronic Breast Pain After Surgery for Breast Cancer.

Study ID: NCT00370240

Conditions

Breast Neoplasms

Pain,Postoperative

Interventions

Chlorhydrate de Ropivacaine

placebo

Study Description

Brief Summary: The aim of the study is to evaluate the effect of local anesthetic (chlorhydrate of ropivacaine) to prevent chronic pain after breast surgery for cancer.

Detailed Description: An estimated 20-65% of women treated with breast surgery for breast cancer experience chronic pain in the treated breast. Patients will be randomize between: infiltration with chlorhydrate of ropivacaine at the time of breast surgery for cancer versus placebo.Intra-operative analgesia will be standardized as well as peri-operative pain management.